<?xml version="1.0" encoding="UTF-8"?>
<p>As shown in Fig. 
 <xref rid="Fig00082" ref-type="fig">8.2</xref>, the purposefully built facilities in our university permit biomass generation and bioprocessing of plant-derived NoV VLP vaccines under cGMP Quality Management System (QMS). For example, separated rooms for buffer preparation, incoming plant samples, chromatography, and sterile fill are purposefully designed in the central bioprocessing suite (Fig. 
 <xref rid="Fig00082" ref-type="fig">8.2a</xref>). 
</p>
